Oté Pharma

What Oté Pharma does

Oté Pharma Sol is a Netherlands-based private medical device company founded in 2006 and headquartered in Uden. The company develops, manufactures, and distributes a complete line of ophthalmic care products, including contact lens solutions for hard and soft lenses (e.g., Oté One Step), contact lenses, eye drops, eye sprays, and accessories, alongside adjacent sterile liquid products such as nasal sprays under contract manufacturing. Its core technology is the formulation, filling, and packaging of sterile liquids in plastic containers under an ISO 13485:2016 quality management system and EU CE marking (Notified Body CE0344), with conformity assessments conducted by DEKRA Certification BV.

The company operates a hybrid business model spanning consumer-branded products and B2B services. Consumer revenue is generated through direct e-commerce on ote.nl and Dutch optical retail channels, supported by participation in optical industry trade shows such as NCC and Opti München. B2B revenue comes from private label manufacturing, with custom branding available from a 1,000-unit minimum order quantity, and full contract manufacturing services covering product design, R&D support, and sterile liquid fill/finish for third-party customers.

Oté serves three primary customer groups: contact lens wearers (B2C) seeking hygiene and comfort products; optical retailers seeking private-label or custom-manufactured eye care lines; and healthcare and pharmaceutical companies seeking a certified OEM partner for sterile liquid medical devices. Geographic presence is concentrated in the Netherlands and broader European markets, with international customers accessed via trade show presence and direct B2B relationships, though the company does not assert a global footprint.

Name

Oté Pharma

Legal name

Oté Pharma Sol

Website

https://otepharma.nl

Company type

Private

Founded year

2006

Operating status

Operating

Short description

Oté Pharma Sol is a Netherlands-based medical device manufacturer and private-label producer of sterile ophthalmic products, including contact lens solutions, eye drops, eye sprays, contact lenses, and related sterile liquids, serving consumer, optical retail, and healthcare/pharma contract manufacturing customers under ISO 13485 and CE compliance.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Eye, Ear & Nasal Care (HLAIADAF)

akta.pro secondary industries

Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays) (CRADAMAG), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Contact lens solutions
• Ophthalmic medical devices
• Eye care products
• Private label manufacturing
• Sterile liquid packaging

Headquarters

HQ city

Uden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Branded Eye Care Products: Direct sales of Oté branded contact lens solutions, eye drops, eye sprays, and accessories through e-commerce and retail channels.
2. Private Label Manufacturing: Custom manufacturing of eye care products under customer's own brand name, with minimum order quantity starting at 1000 units. Includes product development support.
3. Contract Manufacturing Services: Third-party manufacturing services for sterile liquid products in plastic packaging, including product design, R&D support, and full production capabilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Oté Pharma develops, manufactures, and sells sterile liquid medical devices in plastic packaging under its own brand, including contact lens solutions for hard and soft lenses, eye drops, and eye sprays. In parallel, the company offers private label manufacturing (custom branding from 1,000 units) and full contract manufacturing services covering product design, R&D support, and final production of sterile liquids such as nasal sprays for optical retailers, healthcare, and pharmaceutical clients.

Product overview

Oté Pharma is a Dutch eye care company offering a unified product portfolio centered on contact lens and eye care solutions. The core product line includes contact lens care fluids (such as Oté One Step) for hard and soft lenses, contact lenses, eye drops, eye sprays, and accessories. Beyond finished products, Oté offers private label manufacturing (custom branding from 1000 units) and full contract manufacturing services for medical devices including product design, R&D support, and sterile liquid production in plastic packaging. The company positions itself as a reliable partner for high-quality medical devices with ISO 13485 certification and CE compliance.

Differentiator

Problem solved

Functional benefit

Brands

• Oté One Step: Contact lens solution product line.

Products and services

• Oté One Step Branded contact lens solution for both hard and soft contact lenses, part of the Oté complete contact lens care line. Sold to individual contact lens wearers and via optical retailers.
• Contactlensverzorging (Contact Lens Care) Complete line of contact lens care fluids (cleaning, disinfecting, rinsing, storing) for hard and soft contact lenses, sold to individual wearers through the Oté website and optical retailers.
• Contactlenzen (Contact Lenses) Contact lenses offered as part of the Oté product assortment, sold to individual wearers through the Oté website and optical retailers.
• Oogverzorging (Eye Care) Eye care products including eye drops and eye sprays sold to individual consumers for dry, irritated, or sensitive eyes, distributed via the Oté website and optical retailers.
• Accessoires (Accessories) Accessories for contact lens and eye care sold alongside Oté lens care and eye care products to individual consumers and through optical retailers.
• Private Label Private label manufacturing service allowing optical retailers and other partners to produce custom-branded contact lens solutions, eye drops, eye sprays, and related products under their own name, visual, or house style from 1,000 units minimum order quantity.
• Contract Manufacturing Full-service contract manufacturing for medical devices including contact lens solutions, eye drops, and eye sprays, with capabilities for sterile liquids in plastic packaging such as nasal sprays; supports partners from product design through R&D to final production under ISO 13485 and CE marking.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• DEKRA Certification BVcoreOthersDEKRA Certification BV serves as Oté's certification body for conformity assessment of their quality management system and products. DEKRA operates as Notified Body number CE0344 for medical device regulatory compliance, performing audits and assessments of Oté's ISO 13485 quality management system and product certifications.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Menicon: Japanese contact lens and lens care solutions manufacturer (Menicare) with European presence. Directly comparable to Oté's contact lens care product line, though operating at larger scale in Asia-Pacific.
• Théa Laboratories: Independent French specialty ophthalmic pharmaceutical company focused on preservative-free eye drops and sterile ophthalmic formulations. Closest European specialty peer to Oté in product profile and contract manufacturing positioning.
• Similasan: Swiss specialty manufacturer of OTC eye drops and natural homeopathic ophthalmic products. Comparable to Oté as a smaller European specialty eye care brand competing against multinational incumbents.

Broad incumbents

• Bausch + Lomb: Global ophthalmic powerhouse offering contact lens solutions (Renu), eye drops, and other eye care products. Directly comparable to Oté's branded and private label ophthalmic portfolio but at vastly larger scale and global reach.
• CooperVision: Major contact lens manufacturer with branded lens care solutions (Hycosan, etc.). Overlaps with Oté in contact lens care category and shares optical retail distribution channels across Europe.
• Johnson & Johnson Vision: Major contact lens and lens care manufacturer (Acuvue, Blink). Competes with Oté's branded contact lens solutions and serves overlapping optical retail channels in Europe.
• Alcon: World leader in eye care with a comprehensive contact lens care portfolio (Opti-Free) and broad ophthalmic pharmaceutical range. Most direct large-scale competitor to Oté in sterile ophthalmic liquids.
• AMO (AbbVie): Allergan/AbbVie medical aesthetics and eye care division producing ophthalmic pharmaceuticals and lens care products. Overlaps with Oté in ophthalmic pharmaceuticals and competes in eye drop segments.

Emerging players

• Horus Pharma: French independent specialty ophthalmic pharmaceutical company focused on preservative-free eye drops and dry eye products. Similar niche positioning to Oté in European ophthalmic specialty manufacturing.
• TRB Chemedica: European specialty pharmaceutical company with ophthalmic and sterile injectable product lines. Comparable to Oté in operating as a mid-sized specialty sterile manufacturer serving European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oté Pharma